Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Sequencing
Labcorp expands precision oncology offerings
By
Matt Limb
Laboratory services firm Labcorp has announced the expansion of its precision oncology portfolio, aimed at supporting clinical research and advancing drug development programs.
April 12, 2024
Oxford Nanopore, SeqOne to collaborate on sequencing platform
By
LabPulse.com staff writers
Oxford Nanopore and genomics firm SeqOne are collaborating on an end-to-end platform for whole-genome nanopore sequencing reads for clinical diagnostic testing.
March 18, 2024
Curio Bioscience to offer single-cell spatial mapping kit
By
Matt Limb
Curio Bioscience is offering researchers early access to a product which it claims is the first in the world to transform single-cell genomics data into spatial context.
March 19, 2024
NGeneBio, Genolution to collaborate on automated NGS system
By
LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Twist Bioscience, Element Biosciences to collaborate on exome workflow
By
LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience and life science firm Element Biosciences have announced a collaboration to develop a dedicated workflow for Element’s AVITI system.
February 6, 2024
U.K. Health Security Agency unveils five-year pathogen genomics strategy
By
Matt Limb
The U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.
February 1, 2024
Study uncovers role of genetic variants in blood cancer development
By
Matt Limb
Scientists have used large scale data analysis to investigate why only some people with a common mutation go on to develop rare blood cancer.
January 23, 2024
Thermo Fisher goes big with new pangenome array
By
LabPulse.com staff writers
Thermo Fisher Scientific announced the launch of a new human genomics research tool that complements the recent development of the pangenome.
January 5, 2024
Heated legal battles continue in cell-free DNA testing market
By
Liz Carey
Clinical genetic testing manufacturer Natera announced another victory in its fight to stop other companies from capitalizing on cell-free DNA (cfDNA) testing that appears to infringe on its patents. More genetic testing patent disputes are pending.
January 2, 2024
UK Biobank shares 500K WGS linked to 15 years of health data
By
Nick Paul Taylor
UK Biobank has made deidentified whole genome sequencing (WGS) data on 500,000 people available, enabling researchers around the world to analyze the genomics results alongside 15 years of health data on the individuals.
December 4, 2023
Nanopore sequencing slashes tumor analysis times and costs
By
Nick Paul Taylor
Nanopore sequencing makes the analysis of copy number variations (CNVs) faster, cheaper, and simpler, according to a preprint paper from researchers at Dartmouth-Hitchcock Medical Center.
November 28, 2023
Illumina launches pricing program for pathogen sequencing tools in LMICs
By
LabPulse.com staff writers
Illumina has launched its Global Health Access Initiative program to provide pathogen sequencing tools at lower prices in low- and middle-income countries (LMICs).
November 13, 2023
Page 1 of 49
Next Page